<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander, Lori</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Steg, Philippe Gabriel</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Use of Drug-Eluting Stents in Patients with ST-Elevation Myocardial Infarction Increases Mortality Compared to Bare Metal Stenting at 2-Years</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">17-17</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses results that determined the use of drug-eluting stents vs bare metal stents, in patients with ST-elevation myocardial infarction increases all-cause mortality at 2 years.</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>